Your search returned 5 results.

Results
	1.	Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non-Small-Cell Lung Cancer (GALAXY-2). [electronic resource] by Pillai, Rathi N Fennell, Dean A Kovcin, Vladimir Ciuleanu, Tudor-Eliade Ramlau, Rodryg Kowalski, Dariusz Schenker, Michael Yalcin, Ilker Teofilovici, Florentina Vukovic, Vojo M Ramalingam, Suresh S Producer: 20200828 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies. [electronic resource] by Goldman, Jonathan W Raju, Robert N Gordon, Gregory A El-Hariry, Iman Teofilivici, Florentina Vukovic, Vojo M Bradley, Robert Karol, Michael D Chen, Yu Guo, Wei Inoue, Takayo Rosen, Lee S Producer: 20130916 In: BMC cancer vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. [electronic resource] by O'Day, Steven J Eggermont, Alexander M M Chiarion-Sileni, Vanna Kefford, Richard Grob, Jean Jacques Mortier, Laurent Robert, Caroline Schachter, Jacob Testori, Alessandro Mackiewicz, Jacek Friedlander, Philip Garbe, Claus Ugurel, Selma Collichio, Frances Guo, Wei Lufkin, Joelle Bahcall, Safi Vukovic, Vojo Hauschild, Axel Producer: 20130506 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. [electronic resource] by Jhaveri, Komal Chandarlapaty, Sarat Lake, Diana Gilewski, Teresa Robson, Mark Goldfarb, Shari Drullinsky, Pamela Sugarman, Steven Wasserheit-Leiblich, Carolyn Fasano, Julie Moynahan, Mary Ellen D'Andrea, Gabriella Lim, Kristina Reddington, Laura Haque, Sofia Patil, Sujata Bauman, Lynne Vukovic, Vojo El-Hariry, Iman Hudis, Clifford Modi, Shanu Producer: 20141231 In: Clinical breast cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer. [electronic resource] by Socinski, Mark A Goldman, Jonathan El-Hariry, Iman Koczywas, Marianna Vukovic, Vojo Horn, Leora Paschold, Eugene Salgia, Ravi West, Howard Sequist, Lecia V Bonomi, Philip Brahmer, Julie Chen, Lin-Chi Sandler, Alan Belani, Chandra P Webb, Timothy Harper, Harry Huberman, Mark Ramalingam, Suresh Wong, Kwok-Kin Teofilovici, Florentina Guo, Wei Shapiro, Geoffrey I Producer: 20140108 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)